SPH KYUAN

About SPH KYUAN

SPH Kyuan Trade, also known as Keyuan Xinhai (Beijing) Medical Products Trade Co., Ltd., is a key pharmaceutical import and distribution company under Shanghai Pharma, a Fortune Global 500 enterprise. Founded in 2009 and based in the Beijing Tianzhu Comprehensive Bonded Area, the company provides comprehensive, service-oriented solutions for the pharmaceutical industry. Its business operations cover a wide spectrum, including the import of bonded products, pharmaceutical circulation, vaccine services, digital marketing, market access, and extended supply chain services across China. SPH Kyuan Trade offers one-stop import solutions for global pharmaceutical companies, managing over 230 specifications for imported drugs and vaccines.

The company's business model is centered on providing integrated services throughout the entire circulation chain of imported medical products, from customs clearance and bonded processing to warehousing, distribution, and sales. This is supported by a robust distribution network that includes over 1,300 distributors, 2,300 district and county CDCs, and more than 100,000 retail pharmacies. In addition to its core import and distribution activities, SPH Kyuan Trade is involved in clinical trial medication management, cross-border e-commerce, and has expanded into medical beauty, medical equipment, and veterinary medicine. The company operates a wholly-owned subsidiary, Keyuan Xinhai (Beijing) International SCM Co., Ltd., which focuses on port operations, bonded processing, and logistics, leveraging the advantages of the Beijing Tianzhu Free Trade Zone. Through strategic partnerships, such as with Everest Medicines and Asieris Hong Kong, SPH Kyuan facilitates the commercialization and distribution of new drugs in the Chinese market.